OMNIAB, INC. Investing Cash Flow
OMNIAB, INC. (OABI) reported Investing Cash Flow of $814.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- OMNIAB, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$7.62M, a 161.97% decline year-over-year.
- OMNIAB, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $8.44M.
- OMNIAB, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $2.71M, a 604.16% increase year-over-year.
- OMNIAB, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$7.67M, a 272.29% decline year-over-year.
- OMNIAB, INC. net cash provided by (used in) investing activities for fiscal 2025 was $6.47M, a 82.93% decline from fiscal 2024.
- OMNIAB, INC. net cash provided by (used in) investing activities for fiscal 2024 was $37.88M.
- OMNIAB, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$18.38M.
- OMNIAB, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$73.31M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 8 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 11 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$7.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $814.00K 10-Q · filed 2026-08-06 | $3.52M derived: sum of 3 quarters · filed 2026-08-06 | -$4.14M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $8.44M 10-Q · filed 2026-05-07 | $11.15M derived: sum of 2 quarters · filed 2026-05-07 | $3.48M derived: sum of 3 quarters · filed 2026-05-07 | $15.78M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$4.95M derived: sum of 2 quarters · filed 2026-03-04 | $7.34M derived: sum of 3 quarters · filed 2026-08-06 | $6.47M 10-K · filed 2026-03-04 | ||
| 2025-09-30 | -$7.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.63M derived: sum of 2 quarters · filed 2026-08-06 | $3.76M 10-Q · filed 2025-11-04 | $4.14M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $12.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $11.42M 10-Q · filed 2026-08-06 | $11.81M derived: sum of 3 quarters · filed 2026-08-06 | $16.25M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$878.00K 10-Q · filed 2026-05-07 | -$493.00K derived: sum of 2 quarters · filed 2026-05-07 | $3.96M derived: sum of 3 quarters · filed 2026-05-07 | $17.07M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $385.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $4.83M derived: sum of 2 quarters · filed 2026-03-04 | $17.95M derived: sum of 3 quarters · filed 2026-03-04 | $37.88M 10-K · filed 2026-03-04 | ||
| 2024-09-30 | $4.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $17.56M derived: sum of 2 quarters · filed 2025-11-04 | $37.50M 10-Q · filed 2025-11-04 | $42.23M derived: sum of 4 quarters · filed 2025-11-04 | ||
| 2024-06-30 | $13.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $33.05M 10-Q · filed 2025-08-06 | $37.78M derived: sum of 3 quarters · filed 2025-08-06 | $44.07M derived: sum of 4 quarters · filed 2025-08-06 | ||
| 2024-03-31 | $19.94M 10-Q · filed 2025-05-08 | $24.67M derived: sum of 2 quarters · filed 2025-05-08 | $30.95M derived: sum of 3 quarters · filed 2025-05-08 | $38.73M derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $11.02M derived: sum of 2 quarters · filed 2025-03-18 | $18.80M derived: sum of 3 quarters · filed 2025-03-18 | -$18.38M 10-K · filed 2025-03-18 | ||
| 2023-09-30 | $6.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $14.07M derived: sum of 2 quarters · filed 2024-11-12 | -$23.11M 10-Q · filed 2024-11-12 | -$83.31M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $7.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$29.39M 10-Q · filed 2024-08-08 | -$89.59M derived: sum of 3 quarters · filed 2024-08-08 | -$94.47M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$37.17M 10-Q · filed 2024-05-09 | -$97.37M derived: sum of 2 quarters · filed 2024-05-09 | -$102.25M derived: sum of 3 quarters · filed 2024-05-09 | -$106.54M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | -$60.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$65.08M derived: sum of 2 quarters · filed 2024-03-25 | -$69.37M derived: sum of 3 quarters · filed 2024-03-25 | -$73.31M 10-K · filed 2024-03-25 | ||
| 2022-09-30 | -$4.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$9.16M derived: sum of 2 quarters · filed 2023-11-09 | -$13.11M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$4.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$8.24M 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | -$3.95M 10-Q · filed 2023-05-11 | |||||
| 2021-12-31 | -$235.75M 10-K · filed 2022-03-28 | -$4.03M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$235.75M 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |